Results 161 to 170 of about 7,850 (192)

Emergence of carbapenemase-producing Escherichia coli in acute care hospitals in 32 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study.

Lancet Microbe
David S, Kohlenberg A, Yeats C, Abu-Dahab K, Albiger B, Alikhan NF, Alm E, Byfors S, Couto N, Diaz Caballero J, Giske CG, Glasner C, Linkevicius M, Matuschek E, Palm D, Svartström O, Grundmann H, Struelens MJ, Tegmark Wisell K, Monnet DL, Fröding I, Aanensen DM, Brolund A, EURGen-Net CCRE Survey Working Group.   +23 more
europepmc   +1 more source

Community and Clinical Resistomes and Mobilomes: A Correlation

Mahonisi K, Mbanga J, Ismail A, Essack SY.   +3 more
europepmc   +1 more source

Escape from antimicrobial CRISPR-Cas9 in E. coli ST131 depends on the genetic context of the target gene

Morros-Bernaus C, Westley J, Wyrsch ER, Djordjevic SP, Zhang L, Leonard AF, Gaze WH, Sünderhauf D, van Houte S.   +8 more
europepmc   +1 more source

Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: Comparison with H30 and H30-Rx subclones of O25b:H4-ST131

International Journal of Medical Microbiology, 2014
The present study was carried out to evaluate the prevalence of the clonal subgroup O16:H5-ST131 and the H30 and H30-Rx subclones among E. coli isolates causing extraintestinal infections and to know their virulence potential. The ST131 clonal group accounted for 490 (16%) of the 2995 isolates obtained from clinical samples in five Spanish hospitals ...
Ghizlane Dahbi, Azucena Mora, Rosalia Mamaní   +2 more
exaly   +5 more sources

Escherichia coli ST131 Associated with Increased Mortality in Bloodstream Infections from Urinary Tract Source [PDF]

Journal of Clinical Microbiology, 2023
Escherichia coli sequence type 131 (ST131) is a globally dominant multidrug- resistant clone, although its clinical impact on patients with bloodstream infection (BSI) is incompletely understood.
Mark D Adams, Derrick E Fouts, Joshua T Thaden   +2 more
exaly   +2 more sources

Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods [PDF]

Veterinary Microbiology, 2011
Multidrug-resistant Escherichia coli sequence type 131 (ST131) has recently emerged as a globally distributed cause of extraintestinal infections in humans.
James R Johnson, Rowland N Cobbold, Darren J Trott   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Escherichia coli ST1193: Following in the Footsteps of E. coli ST131

Antimicrobial Agents and Chemotherapy, 2022
Escherichia coli ST1193 is an emerging global multidrug (MDR) high-risk clone and an important cause of community-onset urinary and bloodstream infections.
Johann D. D. Pitout, Gisele Peirano, Liang Chen, Rebekah DeVinney, Yasufumi Matsumura   +4 more
openaire   +2 more sources

Escherichia coli ST131: a multidrug-resistant clone primed for global domination [PDF]

F1000Research, 2017
A single extra-intestinal pathogenic Escherichia coli (ExPEC) clone, named sequence type (ST) 131, is responsible for millions of global antimicrobial-resistant (AMR) infections annually. Population genetics indicate that ST131 consists of different clades (i.e. A, B, and C); however, clade C is the most dominant globally.
Johann D D Pitout, Rebekah Devinney
exaly   +3 more sources